Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells
- 15 February 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 288 (3), 259-267
- https://doi.org/10.1016/0922-4106(95)90037-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptideFEBS Letters, 1993
- Molecular Cloning and Functional Expression of Rat cDNAs Encoding the Receptor for Pituitary Adenylate Cyclase Activating Polypeptide (PACAP)Biochemical and Biophysical Research Communications, 1993
- Expression cloning and signaling properties of the rat glucagon receptorScience, 1993
- Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormoneMolecular Endocrinology, 1992
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptideNeuron, 1992
- A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related PeptideScience, 1991
- Expression Cloning of an Adenylate Cyclase-Coupled Calcitonin ReceptorScience, 1991
- Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4‐2JFEBS Letters, 1990
- GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumoursNature, 1989
- DHFR Coamplification of t-PA in DHFR+Bovine Endothelial Cells:In VitroCharacterization of the Purified Serine ProteaseDNA, 1988